Actually the patent application makes no mentions of Vascepa or AMARIN, it does however mention MOCHIDA, Epadel, and even Epanova....no Vascepa.
Vascepa is only mentioned in clinical trial. If GILD didn’t have a relationship with AMARIN I expect they would use icosapent Ethyl in trial and not Vascepa.